As TNF-α is a substrate for ADAM19 [11–13], we hypothesise that the shedding of TNF-α by the ADAM19 metalloproteinase domain potentially exacerbates the pathogenesis of the metabolic syndrome. This evidence concerns the gene ADAM19 and metabolic syndrome.